Carl Torbjörn Bäckström
Director/Board Member at DIAMYD MEDICAL AB
Net worth: 973 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anders Essen-Möller | M | 83 | 28 years | |
| Ulf Hannelius | M | 49 | 8 years | |
| Erik Kjellsson Nerpin | M | 63 | 12 years | |
| Mingde Wang | M | 57 |
Umecrine AB
 Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden.
Obstetrics & Gynecology, Inc.
 Obstetrics & Gynecology, Inc. Medical/Nursing ServicesHealth Services Obstetrics & Gynecology, Inc. engages in providing obstetrics and gynecology (ObGyn) and women's health services. The company is headquartered in St. Louis, MO. | 24 years |
| Magnus Doverskog | M | - |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | - |
| Karin Hehenberger | M | 52 | 3 years | |
| Markus Jerling | M | 72 | - | |
| Mark Atkinson | M | 63 | 6 years | |
| Martina Widman | F | 43 | 8 years | |
| Lars Erik Larsson | M | 72 |
Umea Universitet
| - |
| Anna Styrud | F | 63 | 14 years | |
| Carl Göran Anders Wadell | M | 83 |
Umea Universitet
| - |
| Per Urban Andersson | M | 58 |
Umecrine AB
Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | - |
| Runar Brännlund | M | - |
Umea Universitet
| - |
| Ingrid Elisabet Olivecrona | F | 72 |
Umea Universitet
| - |
| Kjell Göran Sandberg | M | 69 |
Umea Universitet
| - |
| Susanne Eva Lindqvist | M | 64 |
Umea Universitet
| - |
| John Öhd | M | 53 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | - |
| Anton Lindqvist | M | 44 | 11 years | |
| Ole Suhr | M | - |
Umea Universitet
| - |
| Karin Rosen | M | 57 | 1 years | |
| Eva Karlström | F | 60 | 4 years | |
| Christoph Nowak | M | 38 | 3 years | |
| Per Niklas Arnberg | M | 55 |
Umea Universitet
| - |
| Thomas P. Blackburn | M | - |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 7 years |
| Maria-Teresa Essen-Möller | F | 54 | 15 years | |
| Sara Anna Christina Öhrvall | F | 53 |
Umea Universitet
| - |
| Eva Katarina Viola Nygren | F | 69 |
Umea Universitet
| - |
| Bernt Olov Sandberg | M | 72 |
Umea Universitet
| 34 years |
| Lars Emanuel Stenlund | M | 66 |
Umea Universitet
| - |
| Svante Wold | M | - |
Umea Universitet
| 38 years |
| Viktor Drvota | M | 59 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 8 years |
| Anders Eric Karlsson | M | 59 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 2 years |
| Sten Gunnar Otto Skolling | M | 62 |
Umecrine AB
Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | - |
| Ralph Peter Kopelman | M | 66 |
Umea Universitet
| - |
| Göran Johnsson | M | 79 |
Umea Universitet
| - |
| Charles Petter Gustafsson | M | 76 |
Umea Universitet
| - |
| Olof Anton Lindahl | M | - |
Umea Universitet
| - |
| Jinan Li | M | - |
Umea Universitet
| - |
| John Anders Ragnar Bergh | M | - |
Umea Universitet
| - |
| Thomas Borén | M | 64 |
Umea Universitet
| - |
| Bruce F. Scharschmidt | M | 78 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 8 years |
| Tor Ny | M | - |
Umea Universitet
| - |
| Hans Christopher Toll | M | 56 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Per-Olof Bertil Gunnesson | M | 79 |
Umecrine AB
Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 45 | 100.00% |
| United States | 1 | 2.22% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Carl Torbjörn Bäckström
- Personal Network
